2013 US Clinical Chemistry and Immunodiagnostics Markets

NEW YORK, Jan. 3, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2013 US Clinical Chemistry and Immunodiagnostics Markets

http://www.reportlinker.com/p0365428/2013-US-Clinical-Chemistry-and-Immunodiagnostics-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This new report from Venture Planning Group contains 600 pages, 120 tables and presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:

• Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.
• Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
• Five- and ten-year reagent and instrument sales forecasts.
• Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of current and emerging technologies and their potential market applications.
• Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.
• Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Market penetration strategies, entry barriers and risks.

Contains 600 pages and 120 tables

Table of Contents Introduction

Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests

1. Albumin

2. Alkaline Phosphatase

3. ALT/SGPT

4. Ammonia

5. Amylase

6. AST/SGOT

7. Bilirubin, Total

8. Blood Gases

9. Blood Urea Nitrogen (BUN)

10. Calcium

11. Cardio CRP

12. Cholesterol

13. Cholinesterase

14. CRP

15. Creatinine

16. Electrolytes

a. Carbon Dioxide/Bicarbonate

b. Chloride

c. Potassium

d. Sodium

17. Ferritin

18. Fructosamine

19. Gamma-Glutamyl Transpeptidase (GGT)

20. Glucose

21. High Density Lipoprotein (HDL)

22. Homocysteine

23. Iron

24. Lactate Dehydrogenase (LDH)

25. Magnesium

26. Phosphorus

27. Protein

28. Triglycerides

29. Uric Acid

30. Troponin

B. Therapeutic Drug Monitoring (TDM)

1. Overview

2. Carbamazepine

3. Cyclosporin

4. Digoxin

5. Everolimus

6. Gentamicin

7. Lamotrigine/Lamictal

8. Levetiracetam

9. Lidocaine

10. Lithium

11. NAPA/Procainamide

12. Phenytoin

13. Quinidine

14. Sirolimus

15. Tacrolimus

16. Theophylline

17. Topirimate

18. Valproic Acid

C. Endocrine Function Tests

1. Cortisol

2. Follicle-Stimulating Hormone (FSH)

3. Gastrin

4. Growth Hormone/IGF-1

5. Human Chorionic Gonadotropin (HCG)

6. LH

7. PTH/IO PTH

8. Prolactin

9. T3

10. T3 Free

11. T3 Uptake

12. T4 (Thyroxine)

13. T4 Free

14. TBG

15. Thyroglobulin Ab

16. TPO Ab

17. TSH

D. Tumor Markers And Special Chemistry Tests

1. AFP

2. CA 15-3

3. CA 19-9

4. CA 27-29

5. Carcinoembrionic Antigen (CEA)

6. Folate/Folic Acid

7. HCG

8. 25-Hydroxy Vitamin D2 and D3

9. Occult Blood

10. Prostate-Specific Antigen (PSA)

11. Thyroglobulin

12. Vitamin B-12

E. Immunoprotein Tests

1. Complement

a. C3

b. C4

2. Free Light Chains

3. Immunofixation

4. Immunoglobulins (IgA, IgE, IgG, IgM)

5. Haptoglobin

6. Prealbumin

7. Protein Electrophoresis

F. Drugs of Abuse

1. Overview

2. Test Methodologies

3. Amphetamines

4. Barbiturates

5. Benzodiazepines

6. Cannabinoids/Marijuana

7. Cocaine

8. Lysergic Acid Diethylamide (LSD)

9. Methadone

10. Methaqualone

11. Opiates

12. Phencyclidine

13. Tricyclic Antidepressants

G. Instrumentation Review: Operating Characteristics

and Features of High-, Medium-, and Low- Volume/POC

Analyzers Manufactured By:

° Abaxis

° Abbott

° Alere/Inverness

° Alfa Wassermann

° AMS

° Awareness Technologies

° Beckman Coulter /Olympus

° Binding Site

° bioMerieux

° Carolina Chemistries

° DiaSorin

° Grifols

° Horiba

° Medica

° Nova Biomedical

° Ortho-Clinical Diagnostics

° Polymedco

° Randox

° Roche

° Siemens

° Tosoh

° Vital Diagnostics

H. Major In Vitro Diagnostic Technologies

And Their Potential Applications

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays

a. Technological Principle

d. Chemiluminescence

c. Enzyme Immunoassays (EIA)

° Overview

° ELISA

° EMIT

° Electrochemical

d. Radioimmunoassays (RIA)e. Immunoprecipitationf. Affinity Chromatography3. Tandem Mass Spec4. IT and Automation5. Dry Chemistry6. Biosensors U.S.A.A. Executive SummaryB. Business Environment1. Health Care Expenditures2. Cost Consciousness3. Industry Consolidation4. Managed Care5. Hospitals6. Admissions7. Length of Stay8. Industry Diversification9. Physician Demographics10. Population Aginga. Chronic Illnessb. Disease Incidencec. Susceptibility to Iatrogenesisd. Multiple Illness Cases11. Laboratory RegulationsC. Market Structure1. Centralized Testinga. Hospitalsb. Commercial/Private Laboratories2. Decentralized Testinga. Physician Offices/Group Practicesb. Point-of-Care Testingc. Home/Self Testingd. Other Decentralized Testing LocationsD. Market Size, Growth and Major Suppliers'Instrument and Reagent Sales and Market SharesMajor Product Development OpportunitiesDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Assessments- Abbott Laboratories- AdnaGen - Beckman Coulter /Danaher- Biomedical Diagnostics- BioMerieux- Bio-Rad- Dako- DiaSorin- Eiken- Fujirebio- Instrumentation Laboratory- Kyowa Medex- Matritech- Ortho-Clinical Diagnostics- Roche- Siemens- Sysmex- Thermo Fisher - Tosoh- Wako- Wallac/PE

List of Tables Major Companies Developing or Marketing

Albumin Tests

Major Companies Developing or Marketing

Alkaline Phosphatase Tests

Major Companies Developing or Marketing

ALT/SGPT Tests

Major Companies Developing or Marketing

Amylase Tests

Major Companies Developing or Marketing

AST/SGOT Tests

Major Companies Developing or Marketing

Bilirubin Tests

Major Companies Developing or Marketing

Blood Gas Analyzers

Major Companies Developing or Marketing

BUN Tests

Major Companies Developing or Marketing

Calcium Tests

Major Companies Developing or Marketing

Cholesterol Tests

Major Companies Developing or Marketing

Creatinine Tests

Major Companies Developing or Marketing

Electrolyte Tests

Major Companies Developing or MarketingGGT TestsMajor Companies Developing or MarketingGlucose TestsMajor Companies Developing or MarketingHDL Tests Major Companies Developing or MarketingIron TestsMajor Companies Developing or MarketingLDH TestsMajor Companies Developing or MarketingMagnesium TestsMajor Companies Developing or MarketingPhosphorus TestsMajor Companies Developing or MarketingProtein TestsMajor Companies Developing or MarketingTriglycerides TestsMajor Companies Developing or MarketingUric Acid TestsMajor Companies Developing or MarketingTDM TestsMajor Companies Developing or MarketingDigoxin TestsMajor Companies Developing or MarketingLithium TestsMajor Companies Developing or MarketingPhenytoin/Dilantin TestsMajor Companies Developing or MarketingTheophylline TestsMajor Companies Developing or MarketingValproic Acid TestsMajor Companies Developing or MarketingFSH TestsMajor Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingLH TestsMajor Companies Developing or MarketingProlactin TestsMajor Companies Developing or MarketingT3 TestsMajor Companies Developing or MarketingT4 TestsMajor Companies Developing or MarketingTSH TestsMajor Companies Developing or MarketingAFP TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingProstatic Acid Phosphatase TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingVitamin B-12/Folate TestsMajor Companies Developing or MarketingCRP TestsMajor Companies Developing or MarketingDrugs of Abuse TestsMajor Companies Developing or MarketingBiosensors for Immunological TestingExecutive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test CategoryU.S.A., Laboratories Performing Chemistry and Immunoassay Testing By Market SegmentU.S.A., Hospital Laboratories PerformingChemistry and Immunoassay Tests By Bed SizeU.S.A., Commercial/Private LaboratoriesPerforming Chemistry and Immunoassay TestsBy Annual Test VolumeU.S.A., Total Chemistry and ImmunoassaySpecimen Volume ForecastU.S.A., All Market Segments, Specimen VolumeForecast By Test CategoryU.S.A., Total Clinical Chemistry and ImmunoassayTest Volume Forecast By Test CategoryU.S.A., Routine Chemistry Test VolumeForecast By Market SegmentU.S.A., TDM Test Volume Forecast By Market SegmentU.S.A., Endocrine Function Test VolumeForecast By Market SegmentU.S.A., Drugs of Abuse Test VolumeForecast By Market SegmentU.S.A., Tumor Markers and Special ChemistryTest Volume Forecast By Market SegmentU.S.A., Immunoprotein Test VolumeForecast By Market SegmentU.S.A., All Market Segments, Profiles,Panels and Individual Tests ForecastU.S.A., Hospital Laboratories, Profiles,Panels and Individual Tests ForecastU.S.A., Commercial/Private Laboratories,Profiles, Panels and Individual Tests Forecast

U.S.A., Physician Offices/Group Practices,

Profiles, Panels and Individual Tests Forecast

U.S.A., All Market Segments, Routine

Chemistry Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories, Routine

Chemistry Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Routine Chemistry Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Routine Chemistry Test Volume Forecast

by Assay

U.S.A., All Market Segments, TDM

Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, TDM

Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

TDM Test Volume Forecast by Assay

U.S.A., Physician Offices/Group Practices,

TDM Test Volume Forecast by Assay

U.S.A., All Market Segments, Endocrine

Function Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, Endocrine

Function Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Endocrine Function Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Endocrine Function Test Volume Forecast

by Assay

U.S.A., All Market Segments, Drugs

of Abuse Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, Drugs

of Abuse Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Drugs of Abuse Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Drugs of Abuse Test Volume Forecast

by Assay

U.S.A., All Market Segments, Tumor Markers

and Special Chemistry Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories, Tumor Markers

and Special Chemistry Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Tumor Markers and Special Chemistry Test

Volume Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Tumor Markers and Special Chemistry Test

Volume Forecast by Assay

U.S.A., All Market Segments,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Total Clinical Chemistry and Immunoassay

Reagent Market Forecast By Test Category

U.S.A., Clinical Chemistry and Immunoassay

Calibrator and Control Market Forecast

By Test Category

U.S.A., Routine Chemistry Reagent Market

Forecast By Market Segment

U.S.A., TDM Reagent Market Forecast

By Market Segment

U.S.A., Drugs of Abuse Reagent MarketForecast By Market SegmentU.S.A., Tumor Markers and Special ChemistryReagent Market Forecast By Market SegmentU.S.A., Endocrine Function Reagent MarketForecast By Market Segment U.S.A., All Market Segments, RoutineChemistry Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, RoutineChemistry Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,Routine Chemistry Reagent Market Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Routine Chemistry Reagent Market Forecast

by Assay

U.S.A., All Market Segments, TDM

Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, TDM

Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

TDM Reagent Market Forecast by Assay

U.S.A., Physician Office/Group Practices,

TDM Reagent Market Forecast by Assay

U.S.A., All Market Segments, Drugs of

Abuse Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, Drugs of

Abuse Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Drugs of Abuse Reagent Market Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Drugs of Abuse Reagent Market Forecast

by Assay

U.S.A., All Market Segments, Endocrine

Function Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, Endocrine

Function Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Endocrine Function Reagent Market Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Endocrine Function Reagent Market Forecast

by Assay

U.S.A., All Market Segments, Tumor Markers

and Special Chemistry Reagent Market Forecast

by Assay

U.S.A., Hospital Laboratories, Tumor Markers

and Special Chemistry Reagent Market Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., All Market Segments,

Immunoprotein Reagent Market Forecast

U.S.A., Hospital Laboratories,Immunoprotein

Reagent Market Forecast Immunoprotein

U.S.A., Commercial/Private Laboratories,

Immunoprotein Reagent Market Forecast

U.S.A., Physician Offices/Group Practices,

Immunoprotein Reagent Market Forecast

by Assay

U.S.A., Major Suppliers of Clinical Chemistry

Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Clinical ChemistryAnalyzers, Estimated Instrument Sales and Market SharesU.S.A., Major Suppliers of Clinical ChemistryDiagnostics Products, Estimated Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayReagents, Estimated Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayAnalyzers, Estimated Instrument Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayDiagnostics Products, Estimated SalesAnd Market Shares

To order this report:In_Vitro_Diagnostic Industry: 2013 US Clinical Chemistry and Immunodiagnostics Markets

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

RELATED LINKS
http://www.reportlinker.com